A Threat To Monitor Science Is Quashed

WASHINGTON—The research establishment has beaten back Congress’s most serious attempt yet to grab control of investigations and punishment of scientific misconduct. But the victory may be shortlived unless scientists can demonstrate greater will and prowess in policing their own house. The latest threat to the autonomy of universities and other research institutions was a last-minute congressional proposal to create an independent Office of Scientific Integrity. The measure was dra

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON—The research establishment has beaten back Congress’s most serious attempt yet to grab control of investigations and punishment of scientific misconduct. But the victory may be shortlived unless scientists can demonstrate greater will and prowess in policing their own house.

The latest threat to the autonomy of universities and other research institutions was a last-minute congressional proposal to create an independent Office of Scientific Integrity. The measure was drafted by the staff of two influential House members, Rep. John Dingell (D-Mich.) and Rep. Henry Waxman (D-Calif.), chairmen of the House committee and subcommittee that oversee the National Institutes of Health.

The two men offered their changes as an amendment to a bill authorizing ongoing and new programs at NIH. It turned out tobe the wrong strategy. The overall NIH bill contained several controversial provisions, including language on the use of fetal tissue in research that the Senate refused to accept; ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies